Biocatalysis for the asymmetric synthesis of Active Pharmaceutical Ingredients (APIs): this time is for real
- 31 August 2022
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 17 (10) , 1159-1171
Abstract
Biocatalysis has emerged as a powerful and useful strategy for the synthesis of active pharmaceutical ingredients (APIs). The outstanding developments in molecular biology techniques allow nowadays...Keywords
This publication has 95 references indexed in Scilit:
- The use of environmental metrics to evaluate green chemistry improvements to the synthesis of (S,S)-reboxetine succinateGreen Chemistry, 2011
- Commercial Synthesis of (S,S)-Reboxetine Succinate: A Journey To Find the Cheapest Commercial Chemistry for ManufactureOrganic Process Research & Development, 2011
- Sitagliptin Manufacture: A Compelling Tale of Green Chemistry, Process Intensification, and Industrial Asymmetric CatalysisAngewandte Chemie International Edition, 2011
- Applied Biotransformations in Green SolventsChemistry – A European Journal, 2010
- Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin ManufactureScience, 2010
- Development of a Biocatalytic Process as an Alternative to the (−)-DIP-Cl-Mediated Asymmetric Reduction of a Key Intermediate of MontelukastOrganic Process Research & Development, 2009
- A green-by-design biocatalytic process for atorvastatin intermediateGreen Chemistry, 2009
- The Discovery of StatinsCell, 2008
- The power of statins: Aggressive lipid loweringClinical Cardiology, 2003
- Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodesEuropean Neuropsychopharmacology, 1997